You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 14, October 13, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Toward Optimal Laboratory Use
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Strategies for the Review of Transfusion Practices

Leslie E. Silberstein, MD; Margot S. Kruskall, MD; Linda C. Stehling, MD; Marilyn F. M. Johnston, MD, PhD; Roanne C. Rutman, RN(CNAA), MA; Concepcion T. Samia, MT(ASCP)SBB; Glenn Ramsey, MD; Richard S. Eisenstaedt, MD

JAMA. 1989;262(14):1993-1997.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WITH the increased awareness of transfusion-associated human immunodeficiency virus infection, blood transfusion therapy has become an issue of increasing concern to both the general public and to health practitioners. Several measures have already been instituted to reduce the risk of transfusion-related infections: (1) improved screening procedures, (2) early detection of infectious donors by serological methods, (3) institution of confidential donor self-deferral, and (4) inactivation of viruses in some blood products with solvents and detergents.

Although these measures have improved the quality of the blood supply, several important issues, such as other medical complications of blood transfusions, the conservation of limited resources, and cost, remain. Consequently, hospital transfusion committees have been widely used as one mechanism of monitoring blood use by peer review. The Joint Commission on Accreditation of Healthcare Organizations, in Chicago, Ill, has emphasized that the intent of blood use review is, in addition to monitoring transfusion activity, to also . . . [Full Text PDF of this Article]


Author Affiliations

From the Hospital of the University of Pennsylvania, Philadelphia (Dr Silberstein); Beth Israel Hospital, Harvard Medical School, Boston, Mass (Dr Kruskall); the University of New Mexico Hospital, Albuquerque (Dr Stehling); The University Hospital, St Louis, Mo (Dr Johnston); American Red Cross, Missouri-Illinois Region, St Louis (Ms Rutman); Southwest Florida Blood Bank, Tampa (Ms Samia); Central Blood Bank, Pittsburgh, Pa (Dr Ramsey); and Temple University Hospital, Philadelphia (Dr Eisenstaedt). All of the authors are members of the Transfusion Practices Committee of the American Association of Blood Banks, Arlington, Va.


Footnotes

Reprint requests to Blood Bank and Transfusion Medicine Section, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104-4283 (Dr Silberstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.